Page last updated: 2024-10-31

metoprolol and Dysphagia

metoprolol has been researched along with Dysphagia in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
" The robust, scalable technology presented in this study offers an important solution to the long-standing challenges of formulating sustained-release dosage forms suitable for children and older people with swallowing difficulties."1.51Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties. ( Liu, F; Mohylyuk, V; Murnane, D; Patel, K; Richardson, C; Scott, N, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohylyuk, V1
Patel, K1
Scott, N1
Richardson, C1
Murnane, D1
Liu, F1

Other Studies

1 other study available for metoprolol and Dysphagia

ArticleYear
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties.
    AAPS PharmSciTech, 2019, Nov-11, Volume: 21, Issue:1

    Topics: Administration, Oral; Aged; Cellulose; Child; Deglutition Disorders; Delayed-Action Preparations; Dr

2019